Reuters Health: Merkel cell cancers recur more often than other skin cancers

UC expert says early detection of recurrence is important for treatment

New research shows that Merkel cell carcinoma (MCC) recurs in patients much more often than other skin cancers, often within three years of diagnosis.

MCC is a more rare skin cancer that usually appears as a flesh-colored or bluish-red nodule on the skin, often on the face, head or neck.

Rekha Chaudhary, MD, adjunct associate professor at the UC College of Medicine and a UC Health oncologist, reviewed the research and told Reuters Health that new immunotherapy treatments have proven effective against MCC recurrence, making early detection of recurrence important.

"This study was very helpful in predicting those rates of recurrence," she said. "Following an MCC patient who has had a complete resection closely is very important now, given the new innovative treatments, and national guidelines should be adjusted accordingly."

Read the Reuters Health article.

Featured photo at top of Dr. Chaudhary. Photo/Colleen Kelley/University of Cincinnati.

Related Stories

1

WVXU: Tech CEOs talk AI with lawmakers

September 22, 2023

Professor Richard Harknett is a guest speaker on WVXU's Cincinnati Edition on the topic of AI and the need, or lack thereof, for government regulations. Professor Harknett is the head of UC's School of Public and International Affairs and is an often sought out media resource on technology, cybersecurity and governmental affairs.

3

Drugs.com: Lowering blood pressure after clot removal may not be...

September 22, 2023

Drugs.com and HealthDay highlighted University of Cincinnati research recently published in JAMA that found using blood pressure medications to lower the top number of blood pressure readings (systolic blood pressure) may not be safe or effective among people who have an acute ischemic stroke and undergo a successful mechanical clot removal.

Debug Query for this